For: | Gehring S, Kullmer U, Koeppelmann S, Gerner P, Wintermeyer P, Wirth S. Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-α. World J Gastroenterol 2006; 12(36): 5787-5792 [PMID: 17007043 DOI: 10.3748/wjg.v12.i36.5787] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i36/5787.htm |
Number | Citing Articles |
1 |
Chandrasekharan Nair Kesavachandran, Frank Haamann, Albert Nienhaus, Valli De Re. Frequency of Thyroid Dysfunctions during Interferon Alpha Treatment of Single and Combination Therapy in Hepatitis C Virus-Infected Patients: A Systematic Review Based Analysis. PLoS ONE 2013; 8(2): e55364 doi: 10.1371/journal.pone.0055364
|
2 |
Benjamin Morlet, Malak Abou Taam, Voa Ratsimbazafy. Les cytokines du système immunitaire et leurs antagonistes en thérapeutique. Actualités Pharmaceutiques Hospitalières 2009; 5(20): 36 doi: 10.1016/S1769-7344(09)70207-0
|
3 |
Mohammed E. Hamed, Naglaa M. Kamal, Mohammed A. Fouad, Nermin Raafat. Study of non-organ-specific antibodies in Egyptian children with genotype-4 chronic hepatitis C. Egyptian Liver Journal 2014; 4(1): 1 doi: 10.1097/01.ELX.0000440960.79233.17
|
4 |
Neelam Mohan, Regino P González‐Peralta, Tomoo Fujisawa, Mei‐Hwei Chang, Solange Heller, Paloma Jara, Deirdre Kelly, Giorgina Mieli‐Vergani, Uzma Shah, Karen F Murray. Chronic Hepatitis C Virus Infection in Children. Journal of Pediatric Gastroenterology and Nutrition 2010; 50(2): 123 doi: 10.1097/MPG.0b013e3181c61995
|
5 |
James E. Squires, William F. Balistreri. Hepatitis C virus infection in children and adolescents. Hepatology Communications 2017; 1(2): 87 doi: 10.1002/hep4.1028
|
6 |
Patrick Gerner, Juliane Hilbich, Tobias G Wenzl, Rolf Behrens, Frank Walther, Guido Kliemann, Axel Enninger, Stefan Wirth. Re‐treatment of Children With Chronic Hepatitis C Who Did Not Respond to Interferon‐α Treatment. Journal of Pediatric Gastroenterology and Nutrition 2010; 51(2): 187 doi: 10.1097/MPG.0b013e3181d9c7f6
|
7 |
C. Stasi, A. L. Zignego, G. Laffi, M. Rosselli. The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis. Journal of Viral Hepatitis 2011; 18(8): 525 doi: 10.1111/j.1365-2893.2010.01418.x
|
8 |
Giuseppe Indolfi, Elisa Bartolini, Biagio Olivito, Chiara Azzari, Massimo Resti. Autoimmunity and Extrahepatic Manifestations in Treatment-Naïve Children with Chronic Hepatitis C Virus Infection. Clinical and Developmental Immunology 2012; 2012: 1 doi: 10.1155/2012/785627
|
9 |
Pier-Angelo Tovo, Carmelina Calitri, Carlo Scolfaro, Clara Gabiano, Silvia Garazzino. Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression. World Journal of Gastroenterology 2016; 22(4): 1382-1392 doi: 10.3748/wjg.v22.i4.1382
|
10 |
Silvia Garazzino, Carmelina Calitri, Antonella Versace, Alda Alfarano, Carlo Scolfaro, Chiara Bertaina, Simona Vatrano, Federica Mignone, Francesco Licciardi, Clara Gabiano, Pier-Angelo Tovo. Natural history of vertically acquired HCV infection and associated autoimmune phenomena. European Journal of Pediatrics 2014; 173(8): 1025 doi: 10.1007/s00431-014-2286-6
|
11 |
Giuseppe Indolfi, Stefano Stagi, Elisa Bartolini, Roberto Salti, Maurizio De Martino, Chiara Azzari, Massimo Resti. Thyroid function and anti‐thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection. Clinical Endocrinology 2008; 68(1): 117 doi: 10.1111/j.1365-2265.2007.03009.x
|
12 |
Seán J. Costelloe, Nancy Wassef, Josephine Schulz, Tina Vaghijiani, Catherine Morris, Stephen Whiting, Michael Thomas, Geoffrey Dusheiko, Michael Jacobs, Mark P. J. Vanderpump. Thyroid dysfunction in a UK hepatitis C population treated with interferon‐α and ribavirin combination therapy. Clinical Endocrinology 2010; 73(2): 249 doi: 10.1111/j.1365-2265.2010.03785.x
|
13 |
Zehui Yan, Ke Fan, Yi Fan, Xiaohong Wang, Qing Mao, Guohong Deng, Yuming Wang. Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive Factors. Hepatitis Monthly 2012; 12(9) doi: 10.5812/hepatmon.6390
|
14 |
Sevİn Kirdar, Asli Gamze Sener, Merve Cengİz, Nerİman Aydin. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection. APMIS 2016; 124(11): 979 doi: 10.1111/apm.12593
|
15 |
S. Wirth, A. Schmidt-Choudhury, P. Bufler, P. Gerner, W. Huber, T. Lang, M. Melter, E. Pfister. Hepatitis-C-Virusinfektion bei Kindern und Jugendlichen. Monatsschrift Kinderheilkunde 2010; 158(6): 593 doi: 10.1007/s00112-010-2213-5
|
16 |
Corrado Betterle, Fabio Presotto. HCV Infection and Cryoglobulinemia. 2012; : 43 doi: 10.1007/978-88-470-1705-4_5
|
17 |
Corrado Betterle, Fabio Presotto. Terapia con interferoni e autoimmunità organo-specifica: quali rischi e come gestire il paziente. L'Endocrinologo 2010; 11(5): 198 doi: 10.1007/BF03344741
|
18 |
Daniel H. Leung, James E. Squires, Ravi Jhaveri, Nanda Kerkar, Chuan‐Hao Lin, Parvathi Mohan, Karen F. Murray, Regino P. Gonzalez‐Peralta, Eve A. Roberts, Shikha S. Sundaram. Hepatitis C in 2020. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(3): 407 doi: 10.1097/MPG.0000000000002814
|
19 |
James E. Squires, William F. Balistreri. Liver Disease in Children. 2021; : 304 doi: 10.1017/9781108918978.019
|
20 |
Dan Buskila. Hepatitis C–Associated Rheumatic Disorders. Rheumatic Disease Clinics of North America 2009; 35(1): 111 doi: 10.1016/j.rdc.2009.03.005
|